MedTrace Logo

Ketone for Migraine Prevention

NCT05085483 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2023-03-24

No results posted yet for this study

Summary

Efficacy of a nutritional ketogenic supplement (NKS) in reducing the number, intensity, and duration of migraine headaches in episodic migraine patients.

Conditions

  • Migraine Headache

Interventions

DIETARY_SUPPLEMENT

Nutritional Ketogenic Supplement

This trial has 5 steps: (1) a 4-week run-in baseline; (2) a 4-week intervention phase to either active or placebo (3) a 4-week phase of washout; (4) the cross-over to the second 4-week active or placebo phase; (5) a 4-week follow-up.

DIETARY_SUPPLEMENT

Isocaloric placebo supplement

Isocaloric placebo supplement

Sponsors & Collaborators

  • Healint Pte Ltd

    collaborator UNKNOWN

  • Diex Research Sherbrooke Inc.

    collaborator UNKNOWN

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Ginette Girard, MD · Diex Research Sherbrooke Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-11
Primary Completion
2022-11-28
Completion
2022-11-28

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05085483 on ClinicalTrials.gov